The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Fluoro ketone inhibitors of hydrolytic enzymes
Abstract
The use of fluoro ketones as inhibitors of hydrolytic enzymes has been investigated. The acetylcholine analogues 6,6-dimethyl-1,1,1-trifluoro-2-heptanone and 3,3-difluoro-6,6-dimethyl-2-heptanone are inhibitors of acetylcholinesterase with Ki values of 16 X 10(-9) M and 1.6 X 10(-9) M, respectively. These fluoro ketones are 10(4)-10(5) times better as inhibitors than the corresponding methyl ketone. Since nucleophiles readily add to fluoro ketones, it is likely that these compounds inhibit acetylcholinesterase by formation of a stable hemiketal with the active-site serine residue. Fluoro ketone substrate analogues are also inhibitors of zinc metallo- and aspartylproteases. 2-Benzyl-4-oxo-5,5,5-trifluoropentanoic acid is an inhibitor of carboxypeptidase A (Ki = 2 X 10(-7) M). Trifluoromethyl ketone dipeptide analogues are good inhibitors of angiotensin converting enzyme. An analogue of pepstatin that contains a difluorostatone residue in place of statine has been prepared and found to be an extremely potent inhibitor of pepsin (Ki = 6 X 10(-11) M). The hydrated ketones are probably the inhibitory species since they are structural mimics of the tetrahedral intermediate that forms during the hydrolysis of peptide substrates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
Cheung, H. S., Wang, F. L., Ondetti, M. A., Sabo, E. F., & Cushman, D. W. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86187-2 · Cited by 745
[17] The kinetics of reversible tight-binding inhibition
Williams, J. W., & Morrison, J. F. (1979) · Methods in Enzymology · doi:10.1016/0076-6879(79)63019-7 · Cited by 693
TRANSITION STATE ANALOG INHIBITORS AND ENZYME CATALYSIS
Wolfenden, R. (1976) · Annual Review of Biophysics and Bioengineering · doi:10.1146/annurev.bb.05.060176.001415 · Cited by 416
A continuous spectrophotometric assay for angiotensin converting enzyme
Holmquist, B., Bünning, P., & Riordan, J. F. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90769-3 · Cited by 406
[47] A centrifuged-column procedure for the measurement of ligand binding by beef heart F1
Penefsky, H. S. (1979) · Methods in Enzymology · doi:10.1016/0076-6879(79)56050-9 · Cited by 361
The Reversible Hydration of Carbonyl Compounds
Bell, R. P. (1966) · Advances in Physical Organic Chemistry · doi:10.1016/s0065-3160(08)60351-2 · Cited by 287
Mode of inhibition of acid proteases by pepstatin.
Marciniszyn, J., Hartsuck, J. A., & Tang, J. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32945-9 · Cited by 239
Angiotensin‐converting enzyme inhibitors: Medicinal chemistry and biological actions
Petrillo, E. W., & Ondetti, M. A. (1982) · Medicinal Research Reviews · doi:10.1002/med.2610020103 · Cited by 192
Trifluoromethylketones as possible transition state analog inhibitors of juvenile hormone esterase
Hammock, B. D., Wing, K. D., McLaughlin, J., Lovell, V. M., & Sparks, T. C. (1982) · Pesticide Biochemistry and Physiology · doi:10.1016/0048-3575(82)90128-6 · Cited by 96
Cited by
Light-Directed, Spatially Addressable Parallel Chemical Synthesis
Fodor, S. P. A., Read, J. L., Pirrung, M. C., Stryer, L., Lu, A. T., & Solas, D. (1991) · Science · doi:10.1126/science.1990438 · Cited by 2,696
Lindley, J. (1984) · Tetrahedron · doi:10.1016/s0040-4020(01)91791-0 · Cited by 2,253
Fluorine in Medicinal Chemistry and Chemical Biology
(2009) · Wiley eBooks · doi:10.1002/9781444312096 · Cited by 1,731
Fluorination in Medicinal Chemistry: Methods, Strategies, and Recent Developments
Kirk, K. L. (2008) · Organic Process Research & Development · doi:10.1021/op700134j · Cited by 1,151
Welch, J. T. (1987) · Tetrahedron · doi:10.1016/s0040-4020(01)90286-8 · Cited by 1,136
The Behavior and Significance of Slow‐Binding Enzyme Inhibitors
Morrison, J. F., & Walsh, C. T. (1988) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470123072.ch5 · Cited by 840
Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S.-H. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01461 · Cited by 775
Cysteine Proteases and Their Inhibitors
Otto, H.-H., & Schirmeister, T. (1997) · Chemical Reviews · doi:10.1021/cr950025u · Cited by 759
Human carboxylesterases: a comprehensive review
Wang, D., Zou, L., Jin, Q., Hou, J., Ge, G., & Yang, L. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.05.005 · Cited by 543
Köller, W. (1991) · The Fungal Spore and Disease Initiation in Plants and Animals · doi:10.1007/978-1-4899-2635-7_10 · Cited by 460
Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2
Street, I. P., Lin, H. K., Laliberte, F., Ghomashchi, F., Wang, Z., Perrier, H., Tremblay, N. M., Huang, Z., Weech, P. K., & Gelb, M. H. (1993) · Biochemistry · doi:10.1021/bi00074a003 · Cited by 418
Self-citationStructure and Mechanism of the Pepsin-Like Family of Aspartic Peptidases
Dunn, B. M. (2002) · Chemical Reviews · doi:10.1021/cr010167q · Cited by 372
The HIV-1 Protease as a Therapeutic Target for AIDS
DEBOUCK, C. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.153 · Cited by 341
Decroos, C., Bowman, C. M., & Christianson, D. W. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.05.045 · Cited by 17
Decroos, C., & Christianson, D. W. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00536 · Cited by 12
Metadata
- Authors
- Gelb, M. H., Svaren, J. P., & Abeles, R. H.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1985-04-09
- Volume
- 24
- Issue
- 8
- Pages
- 1813-1817
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W1980744726
- Cited by
- 343
- References
- 11
- FWCI
- 17.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.